# Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immunogenicity-durability-and-safety-of-an-mrna-and-three-platform-based-covid/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuemiao Zhang,Xupu Ma,Guanghong Yan,Ying Wu,Yanli Chen,Zumi Zhou,Na Wan,Wei Su,Fengwei Liu,Muxian Dai,Mei Yang,Chunmei Li,Xuanjing Yu,Liang Zhang,Zhongfang Wang,Taicheng Zhou,Dingyun You,Jia Wei,Zijie Zhang |
| Citations | 39 |
| DOI | 10.1016/j.eclinm.2022.101680 |
| Fields | Agricultural and Biological Sciences,Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.eclinm.2022.101680 |
| OpenAlex ID | https://openalex.org/W4297502456 |
| PMID | 36188435 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Yuemiao Zhang](https://scholariq.org/researchers/yuemiao-zhang/)

## Paper journal

- [EClinicalMedicine](https://scholariq.org/journals/eclinicalmedicine/)

## Paper primary topic

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Paper topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches/)
- [Animal Virus Infections Studies](https://scholariq.org/topics/animal-virus-infections-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.